Sitagliptin improves diastolic cardiac function but not cardiorespiratory fitness in adults with type 2 diabetes

Rebecca L. Scalzo(University of Colorado Anschutz Medical Campus), Judith G. Regensteiner(Christian Doppler Laboratory for Thermoelectricity), Amy G. Huebschmann(University of Colorado Anschutz Medical Campus), Deirdre Rafferty(University of Colorado Denver), Melanie Cree‐Green(University of Colorado Boulder), Irene E. Schauer(Rocky Mountain MS Center), Jane E.B. Reusch(United States Department of Veterans Affairs)
Journal of Diabetes and its Complications
May 10, 2019
10.1016/j.jdiacomp.2019.05.002
Cited by 12

Related Papers

2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease
|Journal of the American College of Cardiology|2017|1.9k
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2016|1.1k
2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
|Circulation|2016|1k
Fructose and sugar: A major mediator of non-alcoholic fatty liver disease
|Journal of Hepatology|2018|938
Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial
|The Lancet Diabetes & Endocrinology|2016|728